Danny Incarnato

CSO @ Serna Bio arrow icon

About Danny Incarnato

Danny Incarnato, CSO and PhD in molecular biotechnologies, is renowned for his pioneering work in RNA structure and computational biology.

Known information

Danny Incarnato serves as the Chief Scientific Officer (CSO) and holds a PhD in molecular biotechnologies from the University of Siena. He is an expert in RNA structure and computational biology, currently leading research in this field at the University of Groningen. His significant contributions include the development of innovative experimental and computational tools for RNA structure analysis, which have gained widespread adoption in both academic and industrial settings. Notably, his laboratory was the first to solve the structure of the SARS-CoV-2 RNA genome in living infected host cells during the early stages of the COVID-19 pandemic.

About Serna Bio

Serna Bio, formerly Ladder Therapeutics (LTX), is a biotech company specializing in the development of novel therapeutics targeting the transcriptome for diseases with high unmet medical needs.

report flag Report inaccurate information

People similar to Danny Incarnato

Rabia Khan, CEO with a PhD in Human Genetics and an MBA, has held influential roles in major biotech firms and is dedicated to promoting diversity in STEM.

Tim Allen

Head of ChemAI @ Serna Bio

Tim Allen is the Head of ChemAI, known for his contributions to defining chemical rules for RNA binders and the development of STaR rules.

Francisco Guedes is a research scientist known for his contributions to computational biology, with an educational background from MIT, the University of Cambridge, and Brown University.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free